VEGF-A Splice Variants: Do They Play a Role in Tumor Responses to Anti-Angiogenic Therapies? - Archive ouverte HAL Access content directly
Journal Articles Molecular mechanisms of angiogenesis Year : 2014

VEGF-A Splice Variants: Do They Play a Role in Tumor Responses to Anti-Angiogenic Therapies?

(1, 2) , (1, 2) , (1, 2)
1
2

Abstract

It has been known for two decades that VEGF-A encodes several VEGF-A splice variants, which are termed VEGFxxx, according to the total number of amino acids in the mature protein. To date, nine VEGFxxx isoforms have been described, displaying different biodistributions and pro-angiogenic activities. Adding another level of complexity to VEGF-A biology, a new family of VEGF-A isoforms, termed VEGFxxxb, which exert anti-angiogenic functions, was discovered in 2002 and only differs from VEGFxxx polypeptides with regard to their six C-terminal amino acids. Therefore, reminiscent of what is observed, for instance, during apoptosis, the alternative splicing of VEGF-A pre-mRNA generates two types of isoforms with antagonistic biological functions. As anti-angiogenic therapies target both the VEGFxxx and VEGFxxxb families, VEGF-A pre-mRNA splicing may therefore impact tumor responses to these therapies. Consistently, recent clinical studies have highlighted VEGF-A splice variants as predictive biomarkers in response to bevacizumab. Hence, identification of the upstream signaling pathways that control VEGF-A pre-mRNA splicing, better characterization of the specific biological functions played by each VEGF-A splice variant, and analysis of the impact of anti-angiogenic therapies on VEGF-A pre-mRNA splicing are critical goals. The purpose of this chapter is to summarize the current knowledge in this field.
Fichier principal
Vignette du fichier
Eymin Edited Angiogenesis 2013.pdf (280.52 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-02337585 , version 1 (29-10-2019)

Identifiers

  • HAL Id : inserm-02337585 , version 1

Cite

Béatrice Eymin, Asma Boudria, Cherine Abou-Fayçal. VEGF-A Splice Variants: Do They Play a Role in Tumor Responses to Anti-Angiogenic Therapies?. Molecular mechanisms of angiogenesis, 2014. ⟨inserm-02337585⟩

Collections

INSERM UGA U823
25 View
38 Download

Share

Gmail Facebook Twitter LinkedIn More